Ann Berman Biography and Net Worth

Director of Cantel Medical


Ann E. Berman CPA serves as Independent Director of the Company. Ms. Berman served as a Senior Advisor to the President of Harvard University from April 2006 to June 2009 and as the Vice President of Finance and Chief Financial Officer of Harvard University from October 2002 to April 2006. Ms. Berman has served as a Director of Cantel Medical Corp. since March 2011 and a Director of Loews Corporation since 2006. Ms. Berman brings to her service on the Board accounting and financial management expertise, including extensive risk management experience gained during her tenure at Harvard University, where she served on the Board of Harvard Management Company as well as having responsibilities for finance and research administration as the Chief Financial Officer. In addition to her experience on the boards and audit committees of other public companies, Ms. Berman serves on the Board of Beth Israel Deaconess Medical Center, where she chairs the Compliance and Risk Committee.

What is Ann E. Berman's net worth?

The estimated net worth of Ann E. Berman is at least $537.35 thousand as of December 1st, 2025. Ms. Berman owns 6,686 shares of Cantel Medical stock worth more than $537,354 as of December 5th. This net worth approximation does not reflect any other investments that Ms. Berman may own. Learn More about Ann E. Berman's net worth.

How do I contact Ann E. Berman?

The corporate mailing address for Ms. Berman and other Cantel Medical executives is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. Cantel Medical can also be reached via phone at 973-890-7220 and via email at [email protected]. Learn More on Ann E. Berman's contact information.

Has Ann E. Berman been buying or selling shares of Cantel Medical?

Ann E. Berman has not been actively trading shares of Cantel Medical during the last ninety days. Most recently, Ann E. Berman sold 5,500 shares of the business's stock in a transaction on Monday, April 5th. The shares were sold at an average price of $82.41, for a transaction totalling $453,255.00. Following the completion of the sale, the director now directly owns 4,159 shares of the company's stock, valued at $342,743.19. Learn More on Ann E. Berman's trading history.

Who are Cantel Medical's active insiders?

Cantel Medical's insider roster includes Ann Berman (Director), and Brian Capone (SVP). Learn More on Cantel Medical's active insiders.

Ann E. Berman Insider Trading History at Cantel Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Sell5,500$82.41$453,255.004,159View SEC Filing Icon  
9/30/2016Sell1,453$77.56$112,694.685,424View SEC Filing Icon  
10/5/2015Sell2,462$56.67$139,521.546,130View SEC Filing Icon  
3/13/2015Sell3,135$45.96$144,084.60View SEC Filing Icon  
10/13/2014Sell3,750$37.00$138,750.00View SEC Filing Icon  
See Full Table

Ann E. Berman Buying and Selling Activity at Cantel Medical

This chart shows Ann E Berman's buying and selling at Cantel Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cantel Medical Company Overview

Cantel Medical logo
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Read More

Today's Range

Now: $80.37
Low: $80.37
High: $80.37

50 Day Range

MA: $82.48
Low: $80.37
High: $88.79

2 Week Range

Now: $80.37
Low: $39.40
High: $89.76

Volume

N/A

Average Volume

626,604 shs

Market Capitalization

$3.58 billion

P/E Ratio

69.28

Dividend Yield

0.26%

Beta

1.55